News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
518,896 Results
Type
Article (27387)
Company Profile (542)
Press Release (490962)
Multimedia
Podcasts (188)
Webinars (23)
Section
Business (164987)
Career Advice (1750)
Deals (23948)
Drug Delivery (118)
Drug Development (65819)
Employer Resources (102)
FDA (11128)
Job Trends (10391)
News (246181)
Policy (18797)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (1754)
Academic (1)
Accelerated approval (49)
ADA (49)
Adcomms (29)
Allergies (177)
Alliances (28702)
ALS (225)
Alzheimer's disease (1573)
Antibody-drug conjugate (ADC) (538)
Approvals (11637)
Artificial intelligence (724)
ASCO (314)
Autoimmune disease (358)
Automation (55)
Bankruptcy (181)
Best Places to Work (8760)
BIO (73)
BIOSECURE Act (20)
Biosimilars (209)
Biotechnology (326)
Bladder cancer (210)
Brain cancer (80)
Breast cancer (798)
Cancer (6170)
Cardiovascular disease (514)
Career advice (1430)
Career pathing (41)
CAR-T (355)
CDC (48)
Celiac Disease (3)
Cell therapy (960)
Cervical cancer (53)
Clinical research (59760)
Collaboration (2090)
Commercialization (1)
Company closure (6)
Compensation (1326)
Complete response letters (87)
COVID-19 (2190)
CRISPR (116)
C-suite (1211)
Cystic fibrosis (138)
Data (8456)
Decentralized trials (3)
Denatured (61)
Depression (167)
Dermatology (101)
Diabetes (644)
Diagnostics (5002)
Digital health (52)
Diversity (11)
Diversity, equity & inclusion (24)
Drug discovery (387)
Drug pricing (143)
Drug shortages (24)
Duchenne muscular dystrophy (301)
Earnings (79154)
Editorial (64)
Employer branding (10)
Employer resources (91)
Events (102494)
Executive appointments (1086)
FDA (14945)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (37)
Funding (1801)
Gene editing (250)
Generative AI (77)
Gene therapy (739)
GLP-1 (1010)
Government (3206)
Grass and pollen (6)
Guidances (412)
Healthcare (13294)
Hematology (177)
HIV (90)
Huntington's disease (70)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (117)
Immunology and inflammation (324)
Immuno-oncology (105)
Indications (214)
Infectious disease (2539)
Inflammatory bowel disease (207)
Inflation Reduction Act (14)
Influenza (139)
Intellectual property (264)
Interviews (320)
IPO (13016)
IRA (46)
Job creations (2047)
Job search strategy (1206)
JPM (59)
Kidney cancer (24)
Labor market (104)
Layoffs (424)
Leadership (45)
Legal (3341)
Liver cancer (90)
Longevity (32)
Lung cancer (815)
Lymphoma (469)
Machine learning (60)
Management (37)
Manufacturing (1012)
Marketing (7)
MASH (221)
Medical affairs (1)
Medical device (9413)
Medtech (9575)
Mergers & acquisitions (12182)
Metabolic disorders (1630)
mRNA (271)
Multiple sclerosis (199)
NASH (20)
Neurodegenerative disease (496)
Neuropsychiatric disorders (112)
Neuroscience (3199)
Neurotech (2)
NextGen: Class of 2026 (4361)
Non-profit (3046)
Now hiring (46)
Obesity (749)
Opinion (273)
Ovarian cancer (227)
Pain (251)
Pancreatic cancer (338)
Parkinson's disease (388)
Partnered (29)
Patents (533)
Patient recruitment (748)
Peanut (58)
People (41595)
Pharmaceutical (78)
Pharmacy benefit managers (23)
Phase 1 (17726)
Phase 2 (25780)
Phase 3 (21578)
Pipeline (9600)
Policy (268)
Postmarket research (1717)
Preclinical (6931)
Press Release (56)
Prostate cancer (331)
Psychedelics (67)
Radiopharmaceuticals (304)
Rare diseases (1149)
Real estate (3417)
Recruiting (40)
Regulatory (17498)
Reports (48)
Research institute (1740)
Resumes & cover letters (305)
Rett syndrome (47)
RNA editing (28)
RSV (85)
Schizophrenia (186)
Series A (315)
Series B (228)
Service/supplier (14)
Sickle cell disease (117)
Special edition (31)
Spinal muscular atrophy (163)
Sponsored (38)
Startups (2550)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (70)
The Weekly (126)
Vaccines (1114)
Venture capital (129)
Weight loss (489)
Women's health (128)
Worklife (17)
Date
Today (59)
Last 7 days (471)
Last 30 days (1895)
Last 365 days (28992)
2026 (16255)
2025 (28780)
2024 (31346)
2023 (32527)
2022 (39749)
2021 (42255)
2020 (39087)
2019 (31746)
2018 (24113)
2017 (23736)
2016 (22156)
2015 (26364)
2014 (20301)
2013 (15953)
2012 (16919)
2011 (17992)
2010 (15948)
Location
Africa (587)
Alabama (96)
Alaska (7)
Arizona (244)
Arkansas (15)
Asia (30430)
Australia (5503)
California (13489)
Canada (3506)
China (1449)
Colorado (536)
Connecticut (598)
Delaware (414)
Europe (69007)
Florida (1849)
Georgia (400)
Hawaii (4)
Idaho (40)
Illinois (1164)
India (83)
Indiana (614)
Iowa (24)
Japan (604)
Kansas (122)
Kentucky (43)
Louisiana (59)
Maine (69)
Maryland (1583)
Massachusetts (9963)
Michigan (356)
Minnesota (695)
Mississippi (6)
Missouri (139)
Montana (28)
Nebraska (19)
Nevada (143)
New Hampshire (76)
New Jersey (3533)
New Mexico (31)
New York (3479)
North Carolina (1700)
North Dakota (10)
Northern California (6790)
Ohio (396)
Oklahoma (23)
Oregon (30)
Pennsylvania (2545)
Puerto Rico (30)
Rhode Island (41)
South America (817)
South Carolina (58)
South Dakota (1)
Southern California (5326)
Tennessee (187)
Texas (2133)
United States (47092)
Utah (346)
Vermont (1)
Virginia (308)
Washington D.C. (68)
Washington State (1128)
West Virginia (3)
Wisconsin (148)
Wyoming (1)
518,896 Results for "m3 biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Approves Edwards Lifesciences’ SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
December 24, 2025
·
4 min read
Press Releases
Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025
October 28, 2025
·
4 min read
Press Releases
IGC Pharma Reports IGC-M3’s In Vitro Efficacy Against Alzheimer’s - Targeting key Drivers of Disease Progression
August 6, 2025
·
5 min read
Press Releases
IGC Pharma Highlights Alzheimer’s Pipeline with Encouraging Preclinical Data on IGC-M3 and Advancing Phase 2 Cannabinoid-Based IGC-AD1
August 12, 2025
·
5 min read
Press Releases
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
April 14, 2025
·
4 min read
Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce Tertiary Lymphoid Structures in Tumors
Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions, is today presenting data on its M300 program in a late-breaking poster session at the 2024 American Association for Cancer Research (AACR) meeting.
April 8, 2024
·
3 min read
Business
M3 Wake Research Welcomes New COO
M3 Wake Research, a leading fully integrated network of clinical research sites and one of North America’s largest providers of Phase I-IV clinical trials, welcomes a new Chief Operations Officer, Lynn King.
October 19, 2022
·
3 min read
News
Simulmedia Announces Partnership with M3 MI’s MARS Consumer Health Study to Enable Pharma Marketers to Reach Target Patient Audiences Through Consent-Based Data
September 17, 2024
·
4 min read
Genetown
Mestag Therapeutics’ M300 Program, Designed to Conditionally Induce Tertiary Lymphoid Structures in Tumors, Selected for Late-Breaking Poster Presentation at AACR Annual Meeting
Mestag Therapeutics announced the acceptance of a late-breaking abstract titled “Conditionally active, therapeutic lymphotoxin beta receptor agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors” for presentation at the American Association for Cancer Research meeting taking place April 5-10, 2024 in San Diego, CA.
March 5, 2024
·
2 min read
FDA
FDA clears RF Medical’s MYGEN™ M-3004 and MYOBLATE™ Radiofrequency Ablation System
RF Medical Co., Ltd. is a premier Korean-based medical company serving the healthcare industry for almost two decades. Recently, FDA cleared RF Medical’s patented MYGEN™ M-3004 generator and MYOBLATE™ radiofrequency ablation system.
December 12, 2022
·
2 min read
1 of 51,890
Next
